1. Home
  2. IPW vs BBLG Comparison

IPW vs BBLG Comparison

Compare IPW & BBLG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo iPower Inc.

IPW

iPower Inc.

BUY

Current Price

$0.40

Market Cap

1.1M

ML Signal

BUY

BBLG

Bone Biologics Corp

HOLD

Current Price

$0.39

Market Cap

1.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
IPW
BBLG
Founded
2018
2004
Country
United States
United States
Employees
4
N/A
Industry
Catalog/Specialty Distribution
Industrial Specialties
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.1M
1.2M
IPO Year
2021
2014

Fundamental Metrics

Financial Performance
Metric
IPW
BBLG
Price
$0.40
$0.39
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
★ 1.8M
50.8K
Earning Date
10-02-2026
11-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 45.13
EPS
N/A
★ N/A
Revenue
$19,956,938.00
★ $1,070,000,000.00
Revenue This Year
$596.00
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$0.34
$0.38
52 Week High
$4,092,187,400.00
$5.20

Technical Indicators

Market Signals
Indicator
IPW
BBLG
Relative Strength Index (RSI) 24.74 16.96
Support Level N/A N/A
Resistance Level $1.57 $1.18
Average True Range (ATR) 0.16 0.03
MACD 34.28 0.01
Stochastic Oscillator 4.85 18.11

Price Performance

Historical Comparison
IPW
BBLG

About IPW iPower Inc.

iPower Inc is a technology-enabled commerce infrastructure company providing supply chain, logistics, fulfillment, warehousing and procurement solutions for e-commerce and distribution channels. Its product portfolio includes hydroponic products, gardening supplies, home goods and related accessories, with gardening and home products. Geographically, the company generates majority of its revenue from the United States, followed by Canada and other international markets.

About BBLG Bone Biologics Corp

Bone Biologics Corp a medical device company that is currently focused on bone regeneration in spinal fusion using the recombinant human protein known as NELL-1. NELL-1 in combination with DBM, demineralized bone matrix, is an osteopromotive recombinant protein that provides target specific control over bone regeneration. It is a clinical-stage entity. The production and marketing of its products and ongoing research and development activities are subject to extensive regulation by numerous governmental authorities in the United States.

Share on Social Networks: